Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sellas Life Sciences Group
National Institutes of Health Clinical Center (CC)
Prelude Therapeutics
CellCentric Ltd.
M.D. Anderson Cancer Center
AbbVie
OHSU Knight Cancer Institute
Prelude Therapeutics
AbbVie